Income Tax Expense (Benefit) of Klotho Neurosciences, Inc. from 30 Sep 2022 to 31 Mar 2024

Taxonomy & unit: us-gaap: USD
Description: Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary: Klotho Neurosciences, Inc. quarterly and annual Income Tax Expense (Benefit) in USD history and change rate from 30 Sep 2022 to 31 Mar 2024.
Klotho Neurosciences, Inc. Income Tax Expense (Benefit) for the quarter ending 31 Mar 2024 was $49,069, a 81% decline year-over-year.
Klotho Neurosciences, Inc. Income Tax Expense (Benefit) for the twelve months ending 31 Mar 2024 was $483,868.
Klotho Neurosciences, Inc. annual Income Tax Expense (Benefit) for 2023 was $690,572, a 114% increase from 2022.
Source SEC data: View on sec.gov

Income Tax Expense (Benefit), Trailing 12 Months (USD)

Income Tax Expense (Benefit), Quarterly (USD)

Income Tax Expense (Benefit), YoY Quarterly Change (%)

Income Tax Expense (Benefit), Annual (USD)

Income Tax Expense (Benefit), YoY Annual Change (%)

Klotho Neurosciences, Inc. Quarterly Income Tax Expense (Benefit) (USD)

Period	TTM Value	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed	Fiscal Year	Fiscal Period
Q1 2024	$483,868	$49,069	-$206,704	-81%	01 Jan 2024	31 Mar 2024	10-Q	23 May 2024	2024	Q1
Q4 2023	$690,572	$111,995			01 Oct 2023	31 Dec 2023	10-K	17 Apr 2024	2023	FY
Q3 2023		$148,855	+$69,103	+87%	01 Jul 2023	30 Sep 2023	10-Q	17 Nov 2023	2023	Q3
Q2 2023		$173,949			01 Apr 2023	30 Jun 2023	10-Q	21 Aug 2023	2023	Q2
Q1 2023		$255,773			01 Jan 2023	31 Mar 2023	10-Q	23 May 2024	2024	Q1
Q3 2022		$79,752			01 Jul 2022	30 Sep 2022	10-Q	17 Nov 2023	2023	Q3

Period	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed	Fiscal Year	Fiscal Period
2023	$690,572	+$368,547	+114%	01 Jan 2023	31 Dec 2023	10-K	17 Apr 2024	2023	FY
2022	$322,025			01 Jan 2022	31 Dec 2022	10-K	17 Apr 2024	2023	FY

* An asterisk sign (*) next to the value indicates that the value is likely invalid.